Esperion Therapeutics, Inc. (NASDAQ: ESPR)
$2.2900
-0.0100 ( +2.23% ) 2.0M
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
Market Data
Open
$2.2900
Previous close
$2.3000
Volume
2.0M
Market cap
$453.18M
Day range
$2.1870 - $2.3050
52 week range
$1.5800 - $3.9400
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
10-k | Annual reports | 94 | Feb 27, 2024 |
8-k | 8K-related | 15 | Feb 27, 2024 |
8-k | 8K-related | 18 | Jan 22, 2024 |
8-k | 8K-related | 12 | Jan 18, 2024 |
8-k | 8K-related | 16 | Jan 11, 2024 |
8-k | 8K-related | 13 | Jan 03, 2024 |